TerminatedNCT00958633
Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolarity.
Medication studyAges 18–70Canada
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2010
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 237
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00958633
- Official title
Show the full official title
Mood Stabilizer Plus Antidepressant Versus Mood Stabilizer Plus Placebo in the Maintenance Treatment of Bipolar Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Escitalopram and Bupropion XL.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
